Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
8223463 | International Journal of Radiation Oncology*Biology*Physics | 2013 | 7 Pages |
Abstract
In the absence of large prospective trials, the current clinical decision-making of hemangiopericytoma is mostly based on retrospective data. We recommend that postoperative RT be considered after subtotal resection for patients who could tolerate it. Based on the current literature, the practical approach is to deliver limited field RT to doses of 50-60 Gy while respecting the normal tissue tolerance. Further investigations are clearly needed to determine the optimal therapeutic strategy.
Related Topics
Physical Sciences and Engineering
Physics and Astronomy
Radiation
Authors
Alexander M. MD, PhD, Cristina PhD, Jaime MD, Muri MD, Baoqing MD, PhD,